Carelane Raises €800K in Funding to Enhance Clinical Trial Platform

Carelane raises €800K in Pre-Seed Funding

Carelane, a life sciences technology startup, recently secured €800K in Pre-Seed funding to revolutionize clinical trials in the pharmaceutical industry. Their unified platform digitizes study protocols, streamlining operations and improving collaboration between pharmaceutical companies, CROs, and academic researchers.

Funding Amount: €800K

Industry: Financial Services

Employee Count: 2-10

CEO: Rogelio Choy (CEO Linkedin)

What Carelane needs to buy: Cloud technology providers, data security experts, pharmaceutical companies, CROs, and academic institutions are ideal partners for Carelane. These companies can support Carelane in enhancing their platform's performance, expanding its adoption, and driving growth in the life sciences industry.